ZYVOXID 100 mg/5 ml, granules for oral suspension bottle, 66 g
Active ingredients: Linezolid
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Granules for oral suspensionbottle, 66 gorale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- ZYVOXID 100 mg/5 ml, granulés pour suspension buvable
- Pharmaceutical form
- granulés pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun avec fermeture de sécurité enfant de 66 g avec cuillère-mesure
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Dec 2004
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63095061CIP75651268CIP133400956512683Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LINÉZOLIDEgranulés | 100 mg · 5 ml de suspension reconstituée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.